NICE recommends kidney cancer drug it previously rejected on cost grounds.
Mayor
Susan
S
D000970:Antineoplastic Agents / Q000191:economics / Q000627:therapeutic use*; D003362:Cost-Benefit Analysis; D017277:Drug Approval; D016527:Drug Costs; D006801:Humans; D007211:Indoles / Q000191:economics / Q000627:therapeutic use*; D007680:Kidney Neoplasms / Q000188:drug therapy* / Q000191:economics; D011758:Pyrroles / Q000191:economics / Q000627:therapeutic use*; D019057:Quality-Adjusted Life Years; D000077210:Sunitinib; D006113:United Kingdom
D000970:Antineoplastic Agents; D007211:Indoles; D011758:Pyrroles; D000077210:Sunitinib